Skip to main content
Smart Investors Daily
Boston Scientific Corporation logo

NASDAQ · BSX

Boston Scientific Corporation

Healthcare · Medical - Devices

$44.92

Down-$0.30 (-0.67%)

Updated Sep 23, 2026, 11:27 PM

SID Score

4.8/10

Composite research score

Smart Money

74/100

Bullish

Market cap
135.98B
P/E ratio
48.75
Dividend yield
0.00%
52-week range
$42.20 – $100.90
Volume
21.08M
Avg. volume
9.87M

Price performance

BSX price history

1M range · 20 trading sessions · Daily adjusted prices

BSX closed at $44.92 after 20 trading sessions, down 9.91% for the selected period.

Last close
$44.92
Period change
-9.91%
Period low
$42.98
Period high
$49.86
Daily close
View OHLC price history
BSX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 22, 2026$44.70$45.08$44.04$44.9221.08M
Sep 21, 2026$42.98$43.81$42.72$43.7225M
Sep 18, 2026$43.08$43.90$43.05$43.3429.28M
Sep 17, 2026$43.465$43.66$42.95$43.5532.57M
Sep 16, 2026$43.85$44.665$43.6501$43.9128.48M
Sep 15, 2026$44.32$44.9889$43.68$43.8716.02M
Sep 14, 2026$44.00$45.15$43.85$45.0520.52M
Sep 11, 2026$43.19$43.55$42.795$42.9826.99M
Sep 10, 2026$44.13$44.42$42.78$43.1022.69M
Sep 9, 2026$45.105$46.265$44.89$44.9617.98M
Sep 8, 2026$47.43$47.45$44.85$44.9829.03M
Sep 4, 2026$46.92$48.0583$46.83$47.8015.5M
Sep 3, 2026$48.58$49.2656$46.80$46.9519.73M
Sep 2, 2026$47.91$49.66$47.91$48.3717.02M
Sep 1, 2026$49.115$49.115$47.27$48.0812M
Aug 31, 2026$46.40$48.965$46.09$48.3018.91M
Aug 28, 2026$46.85$47.22$46.50$46.8417.15M
Aug 27, 2026$48.00$48.07$46.61$46.6716.28M
Aug 26, 2026$47.00$48.54$46.90$48.1736.58M
Aug 25, 2026$48.79$50.04$48.54$49.8617.37M

Latest BSX news

The latest Smart Investors Daily articles mentioning BSX.

BSX research

Overview

Company profile and research snapshot.

Company profile

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$127.00
Implied upside
Analysts
24
BSX recent ratings
DateFirmRatingTarget
Sep 21, 2026OppenheimerOutperform
Sep 17, 2026CitigroupNeutral
Sep 9, 2026BTIGBuy
Aug 25, 2026TD CowenBuy
Jul 31, 2026Argus ResearchHold
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 17, 2026

Boston Scientific (BSX) Stock Trades At A Discount On A 55% Slump

Boston Scientific has seen its share price fall sharply over the past year, which naturally raises a question for investors who care about fundamentals. Are the cash flows that the business can generate enough to support where the stock trades today, or has sentiment moved further than the underlying economics justify? The share price has declined 55.4% over the past year, so the recent slide puts the focus squarely on whether that move lines up with the cash that Boston Scientific can...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.